TABLE 5.

Summary of Techniques and Drainage Patterns in SLND Series Using Breast Lymphoscintigraphy

StudynAgentTotal MBqTotal injection volume* (mL)Early/late scan timing after injection (h)ViewsOverall sentinel node detection (%)AX drainage (%)IM drainage (%)
TotalExclusiveTotalExclusive
Uren et al. (12)34ASC50–700.2–0.40/2.5A, L, O919458396
Roumen et al. (10)83CA6024/18A, L809786113
De Cicco et al. (9)250CA or ASC70.4 or 0.50.25–0.5/3A, AO98989822
Borgstein et al. (7)130CA4042/18A, L919881182
O'Hea et al. (8)56SC114 0.8–1§   A, L7510086140
van der Ent et al. (11)70NC370416§A, ALNR97NR34NR
Current series76SC12–163–80/A, MOVA1009979201
  • * All injections were peritumoral except for series from De Cicco (9).

  • Values represent drainage patterns after scan failures were excluded.

  • 0.4 mL for subdermal injection (175 patients) and 0.5 mL for peritumoral injection (75 patients).

  • § Only 1 scan obtained at these times.

  • Images obtained continuously until sentinel node visualized, unless no uptake after 4 h.

  • A = anterior; L = lateral; O = oblique; CA = colloidal albumin; AO = antero-oblique; SC = sulfur colloid; NC = nanocolloid; AL = anterolateral; NR = not recorded.